A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY TO DETERMINE THE OPTIMAL DOSE OF HL301 AFTER 7 DAYS ORAL ADMINISTRATION IN ACUTE BRONCHITIS OR ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS PATIENTS (HL301: MIXED EXTRACT OF REHMANNIA GLUTINOSA, SCHISANDRA AND SO ON):